Afabicin, a first-in-class antistaphylococcal antibiotic, in the treatment of acute bacterial skin and skin structure infections: clinical noninferiority to vancomycin/linezolid
Suspected side effects should be reported to the MHRA Yellow Card scheme in addition to informing the clinical trial team
Struggling with weight can affect more than just your physical appearanceit can impact your self-esteem, mood, and overall well-being
It was just very uncomfortable, Beccarelli, 57, who lives in Queens, New York, tells TODAY.com
While the EMA's action represents important progress, critics argue that regulatory agencies have been slow to respond to mounting evidence
i.p.) 24 h apart through intraperitoneal (IP) injection and were sacrificed 2 h after the second injection